Anoumou Claver Dagnra
Dados Biográficos
| ID | 7773254 |
|---|---|
| NOME | Anoumou Claver Dagnra |
| PRENOMES | Anoumou Claver |
| SOBRENOME | Dagnra |
| ASSINATURA | DAGNRA A C |
| AFILIAÇÕES | University of Lomé |
| ORCID | 0000-0003-3201-4063 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2022 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Prevalence of primary HIV-1 drug resistance among antiretroviral-naïve individuals in Togo in 2023
Monitoring pre-treatment drug resistance is a priority to assess the emergence of HIV resistance to antiretrovirals, especially in countries where the transition from dolutegravir-based regimens is already effective on a large scale. The aim of this study was to estimate the prevalence of resistance mutations to different classes of antiretrovirals (ARVs) in HIV-1-naïve persons in Togo in 2023. A cross-sectional study was conducted in 30 HIV care…
Sars-CoV-2 antibody seroprevalence in Togo
The high seroprevalence we observed is consistent with observations across West Africa. Quantification of the level of immunity in the population is needed to know how close we are to herd immunity. In the meantime, vaccination against the COVID-19 remains necessary
Sem obras proeminentes nesta página.
Sars-CoV-2 antibody seroprevalence in Togo
The high seroprevalence we observed is consistent with observations across West Africa. Quantification of the level of immunity in the population is needed to know how close we are to herd immunity. In the meantime, vaccination against the COVID-19 remains necessary
Prevalence of primary HIV-1 drug resistance among antiretroviral-naïve individuals in Togo in 2023
Monitoring pre-treatment drug resistance is a priority to assess the emergence of HIV resistance to antiretrovirals, especially in countries where the transition from dolutegravir-based regimens is already effective on a large scale. The aim of this study was to estimate the prevalence of resistance mutations to different classes of antiretrovirals (ARVs) in HIV-1-naïve persons in Togo in 2023. A cross-sectional study was conducted in 30 HIV care…
Antibody (1 obras) · Biological Research and Disease Studies (1 obras) · COVID-19 Clinical Research Studies (1 obras) · COVID-19 epidemiological studies (1 obras) · Cross-sectional study (1 obras) · Demography (1 obras) · Demography (1 obras) · Dolutegravir (1 obras) · Drug resistance (1 obras) · Elvitegravir (1 obras)